Make your money go further for just 25p per day

PREMIUM

How to profit from advances in genetic medicine

DNA cancer treatment

The pharma industry has not always been kind to the most innovative of companies. But regulation is changing alongside a rising demand for targeted personalised therapies. Pharma companies are beginning to invest in the genetic medicines market, but this European giant is leading the way.


Human evolution naturally takes place over thousands of years. That is why – fashion and hygiene aside – modern humans look very like (and are nearly genetically identical to) the humble homo sapiens which roamed the earth over one million years ago.

It’s true that evolutionary changes have taken place in that time – for example, today’s humans rarely develop a third set of molars and most produce the enzyme which allows them to digest milk.…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world

REGISTER FREE

Fundamental Asset Management
Buy any of our portfolios with our associates.
 

FIND OUT MORE

More on Novartis

How to profit from advances in genetic medicine

24/10/2019 · Portfolio

The pharma industry has not always been kind to the most innovative of companies. But regulation…


More Portfolio

Income Boosters: ahead of the market so far in 2020

06/07/2020

National Grid takes hit from COVID-19 but confirms dividend rise

25/06/2020 · Hikma · National Grid

Quality British stocks retain reliability